COVID-19对加拿大的药物短缺的影响有限
1Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario.
概括
冠状病毒疾病2019 (COVID-19) 流行病在2020年3月至4月期间导致加拿大药物短缺增加32%. 这一由供需问题驱动的增长主要集中在与COVID-19相关的药物中.
科学领域:
- 健康科学 卫生科学 卫生科学
- 流行病学 流行病学
- 制药科学 制药科学
背景情况:
- 2019年冠状病毒疾病 (COVID-19) 流行病的爆发给全球医疗保健系统带来了前所未有的挑战.
- 在此期间,预计供应链中断和对某些药物的需求增加.
研究的目的:
- 为了确定COVID-19大流行初期的几个月是否与加拿大药物短缺的显著增加有关.
- 分析药物短缺的任何观察到的激增的时间,规模和特征.
主要方法:
- 利用来自加拿大药物短缺网站的数据进行分析.
- 将2020年3月和4月报告的药物短缺情况与前几年同期的短缺情况进行了比较.
- 检查了与报告的短缺相关的原因和治疗类.
主要成果:
- 2020年3月和4月与前几年相比,药物短缺的147例 (32%) 显著增加.
- 短缺的激增主要集中在两周内 (2020年3月25日至4月7日).
- 报告的原因包括供给侧和需求侧因素,与COVID-19护理相关的治疗类内的短缺显著增加.
结论:
- COVID-19流行病的早期阶段与加拿大药物短缺的大幅增加有关,尽管是暂时的.
- 供应和需求压力都导致了短缺,特别是影响了COVID-19治疗中使用的药物.
- 这些发现凸显了公共卫生危机期间药物供应链的脆弱性.
更多相关视频
相关概念视频
Prescription, Nonprescription and Orphan Drugs
724
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
724
Factors Affecting Drug Response: Overview
2.0K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.0K
Drug Control Governance: Regulatory Bodies and Their Impact
158
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
158
Drug Classes and Categories
2.0K
Drugs can be classified according to their chemical composition or their intended therapeutic application. For instance, anti-infective agents that possess the ability to eliminate pathogens or suppress their growth and reproduction can be grouped based on the organisms they target or their chemical structure. Furthermore, drugs can be divided into prescription, nonprescription, or controlled substances. Prescription medications, such as antibiotics, require oversight from a licensed healthcare...
2.0K
Time Course of Drug Effect
2.0K
The progression of a drug's impact can be analyzed by examining both the concentration-time course and the effect-time course. The concentration-time course is determined by the drug's half-life and is influenced by factors such as its pharmacokinetics, including absorption, distribution, metabolism, and elimination. The effect of the drug is often related to its concentration in the plasma and is calculated using the maximum drug effect and the plasma concentration that generates 50...
2.0K
Pharmacovigilance
830
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
830


